N@N

Tiago Fauth Maintained (UTHR) at Buy with Increased Target to $325 on, Mar 7th, 2024

Tiago Fauth of Wells Fargo, Maintained "United Therapeutics Corporation" (UTHR) at Buy with Increased Target from $309 to $325 on, Mar 7th, 2024.

Tiago has made no other calls on UTHR in the last 4 months.

There are 4 other peers that have a rating on UTHR. Out of the 4 peers that are also analyzing UTHR, 1 agrees with Tiago's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Chris Shibutani of "Goldman Sachs" Upgraded from Strong Sell to Hold and Increased Target to $215 on, Monday, February 12th, 2024

These are the ratings of the 3 analyists that currently disagree with Tiago

---

• Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $300 on, Thursday, February 22nd, 2024
• Liana Moussatos of "Wedbush" Reiterated at Buy and Held Target at $308 on, Thursday, February 22nd, 2024
• Roanna Ruiz of "Leerink Partners" Initiated at Buy and Held Target at $330 on, Monday, February 5th, 2024

Contributing Sources

---